Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date02 Jan 1982 |
100 Clinical Results associated with Changshu Starsea Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Changshu Starsea Pharmaceutical Co., Ltd.
100 Deals associated with Changshu Starsea Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Changshu Starsea Pharmaceutical Co., Ltd.